Expressions of SAA, CRP, and FERR in different severities of COVID-19
- PMID: 33215460
- DOI: 10.26355/eurrev_202011_23631
Expressions of SAA, CRP, and FERR in different severities of COVID-19
Abstract
Objective: To explore the expression and significance of SAA, CRP and FERR in patients diagnosed with COVID-19.
Patients and methods: A total of 225 patients diagnosed with COVID-19 who were admitted to the North Hospital of First Hospital in Changsha, China, from 9th February 2020 to 7th March 2020 were enrolled. Their general data, laboratory test results and levels of SAA, CRP and FERR were extracted from electronic medical records.
Results: Age was an important risk factor for the severity of COVID-19 in the patients. Compared with the non-severe group, the severe group showed statistical significance in the levels of total protein, albumin, ALT and AST in liver function, UA in renal function, myocardial enzyme CK-MB and LDH, and immunoglobulin IgG and IgM. The levels of SAA, CRP, and FERR were significantly increased in patients with severe COVID-19. ROC curve analysis results showed that the AUC, from small to large, was as follows: SAA+CRP+FERR, CRP + FERR, SAA + CRP, SAA + FERR, SAA, FERR, and CRP, which indicated the benefit of the combination of the three indicators. The sensitivity and specificity of the combined detection of the three indicators were higher than those of the detection of any single indicator or two combined indicators. A Spearman correlation analysis of the data showed that the initial CRP/SAA, SAA/FERR, and CRP/FERR were positively correlated. The continuous results of SAA, CRP and FERR throughout the study period showed that the values of the severe group on a given day were higher than those of the non-severe group; the values of the two groups peaked on the 5th or 7th day and then decreased, and the decreasing trend of the severe group was more evident.
Conclusions: SAA, CRP and FERR are sensitive serological indicators used to evaluate the severity of COVID-19. The combined detection of serum SAA, FERR, and CRP, which are positively related to COVID-19 infection, offers guiding significance for the occurrence of COVID-19 infection and the severity of the disease. Such detection provides effective detection indicators for the progress and prognosis of COVID-19; these indicators will enable effective intervention measures to be implemented in time and the rates of severe illness and mortality to be reduced.
Similar articles
-
Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis.J Infect. 2020 Jun;80(6):646-655. doi: 10.1016/j.jinf.2020.03.035. Epub 2020 Apr 8. J Infect. 2020. PMID: 32277967 Free PMC article.
-
Prognostic value of serum amyloid A in patients with COVID-19.Infection. 2020 Oct;48(5):715-722. doi: 10.1007/s15010-020-01468-7. Epub 2020 Jul 30. Infection. 2020. PMID: 32734556 Free PMC article.
-
Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):536-541. doi: 10.11817/j.issn.1672-7347.2020.200384. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020. PMID: 32879103 Chinese, English.
-
Laboratory findings of COVID-19: a systematic review and meta-analysis.Scand J Clin Lab Invest. 2020 Oct;80(6):441-447. doi: 10.1080/00365513.2020.1768587. Epub 2020 May 23. Scand J Clin Lab Invest. 2020. PMID: 32449374 Free PMC article.
-
Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review.Clin Biochem. 2020 Jul;81:1-8. doi: 10.1016/j.clinbiochem.2020.05.012. Epub 2020 May 27. Clin Biochem. 2020. PMID: 32473151 Free PMC article. Review.
Cited by
-
Serum Amyloid A Protein as a useful biomarker to predict COVID-19 patients severity and prognosis.Int Immunopharmacol. 2021 Jun;95:107512. doi: 10.1016/j.intimp.2021.107512. Epub 2021 Mar 2. Int Immunopharmacol. 2021. PMID: 33735714 Free PMC article.
-
Hypothesis: AA amyloidosis is a factor causing systemic complications after coronavirus disease.Prion. 2021 Dec;15(1):53-55. doi: 10.1080/19336896.2021.1910468. Prion. 2021. PMID: 33876719 Free PMC article.
-
The utility of serum amyloid A and other acute-phase reactants determination in ambulatory care COVID-19 patients.J Med Biochem. 2023 Aug 25;42(3):492-504. doi: 10.5937/jomb0-42799. J Med Biochem. 2023. PMID: 37790210 Free PMC article.
-
Comparison of laboratory parameters in mild vs. severe cases and died vs. survived patients with COVID-19: systematic review and meta-analysis.J Thorac Dis. 2022 May;14(5):1478-1487. doi: 10.21037/jtd-22-345. J Thorac Dis. 2022. PMID: 35693606 Free PMC article.
-
Monocyte distribution width as a novel sepsis indicator in COVID-19 patients.BMC Infect Dis. 2022 Jan 4;22(1):27. doi: 10.1186/s12879-021-07016-4. BMC Infect Dis. 2022. PMID: 34983404 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous